VEGFC and breast cancer: In September 2009, our group initiated a prospective study to determine the value of preoperative serum VEGF-C levels and predict the risk of axillary lymph node involvement in female early breast cancer patients undergoing local surgical treatment and sentinel lymph node biopsy (SLNB).